Global Short Bowel Syndrome Market Dynamics and Growth Rate 2016-2024 Short Bowel Syndrome Market (Drug Class - GLP-2, G | Page 2

Global Short Bowel Syndrome Market: Scope of the Study
Market share analysis among the market players is analyzed to signify the contribution of these players
in the market in terms of percentage share. All these factors will help the market players to decide
about the business strategies and plans to strengthen their positions in the global market. Based on
geography, the market has been analyzed for major regions: North America, Europe, and Rest of the
World. The study also covers detailed country analysis contributing majorly in the short bowel
syndrome market.
Get accurate market forecast and analysis on the Short Bowel Syndrome market. Request
a sample to stay abreast on the key trends impacting this market.
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13346
Key Players Mentioned in this Report are:
The report also profiles the major players in the market and provides various attributes such as
company overview, financial overview, product portfolio, business strategies, and recent
developments. Companies profiled in the short bowel syndrome market report are Ardelyx, Inc.,
Emmaus Life Sciences, Inc., GLyPharma Therapeutic, Inc., Merck KGaA, Naia Pharmaceuticals, Inc.,
Nutrinia Ltd., OxThera, Sancilio & Company, Inc., Shire plc, and Zealand Pharma A/S, among others.
The Short Bowel Syndrome Market has been segmented as follows:


Short Bowel Syndrome Market, by Drug Class, Revenue (US$ Mn) 2014-2024
o GLP-2
o Growth Hormone
o Glutamine
o Others
Short Bowel Syndrome Market Revenue, by Geography (US$ Mn), 2014-2024
o North America
 U.S.
 Canada
o Europe
 U.K.
 Germany
 Spain
 France
 Italy
 Rest of Europe
o Rest of the World
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business
information reports and services. The company’s exclusive blend of quantitative forecasting and trend
analysis provides forward-looking insights for decision makers. TMR’s experienced team of analysts,
researchers, and consultants use proprietary data sources and various tools and techniques to gather
and analyze information.